BR9910449A - Composições orais de 8-cloro-6,11-diidro-11-(4-piperidilideno)-5h-benzo[5,6]c icloepta[1,2-b]piridina - Google Patents
Composições orais de 8-cloro-6,11-diidro-11-(4-piperidilideno)-5h-benzo[5,6]c icloepta[1,2-b]piridinaInfo
- Publication number
- BR9910449A BR9910449A BR9910449-0A BR9910449A BR9910449A BR 9910449 A BR9910449 A BR 9910449A BR 9910449 A BR9910449 A BR 9910449A BR 9910449 A BR9910449 A BR 9910449A
- Authority
- BR
- Brazil
- Prior art keywords
- piperidylidene
- benzo
- pyridine
- icloepta
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11323298A | 1998-07-10 | 1998-07-10 | |
PCT/US1999/012368 WO2000002560A1 (en) | 1998-07-10 | 1999-07-08 | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9910449A true BR9910449A (pt) | 2001-01-02 |
Family
ID=22348307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9910449-0A BR9910449A (pt) | 1998-07-10 | 1999-07-08 | Composições orais de 8-cloro-6,11-diidro-11-(4-piperidilideno)-5h-benzo[5,6]c icloepta[1,2-b]piridina |
Country Status (28)
Country | Link |
---|---|
EP (3) | EP1380297B1 (pt) |
JP (4) | JP3224379B1 (pt) |
KR (1) | KR100420641B1 (pt) |
CN (1) | CN1145485C (pt) |
AR (4) | AR016044A1 (pt) |
AT (2) | ATE432075T1 (pt) |
AU (1) | AU741201B2 (pt) |
BR (1) | BR9910449A (pt) |
CA (2) | CA2325014C (pt) |
CY (1) | CY1109279T1 (pt) |
CZ (1) | CZ300843B6 (pt) |
DE (2) | DE69940932D1 (pt) |
DK (2) | DK1380297T3 (pt) |
ES (2) | ES2326214T3 (pt) |
HK (1) | HK1030361A1 (pt) |
HU (1) | HU228448B1 (pt) |
ID (1) | ID28645A (pt) |
IL (1) | IL139407A0 (pt) |
MY (1) | MY116038A (pt) |
NO (1) | NO331454B1 (pt) |
NZ (2) | NZ512916A (pt) |
PE (1) | PE20000761A1 (pt) |
PL (1) | PL199390B1 (pt) |
PT (2) | PT1073438E (pt) |
SK (1) | SK288240B6 (pt) |
TW (1) | TW575424B (pt) |
WO (1) | WO2000002560A1 (pt) |
ZA (1) | ZA200006224B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045668A2 (en) | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
AU2276801A (en) | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
US7507714B2 (en) | 2000-09-27 | 2009-03-24 | Bayer Corporation | Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use |
BRPI0513417A (pt) * | 2004-07-16 | 2008-05-06 | Cipla Ltd | composição farmacêutica estável, usos de um poliol, e de uma composição, processo para preparar uma composição farmacêutica, e, método para tratar uma condição responsiva à administração de uma anti-histamina |
EP2181994B1 (en) | 2006-03-31 | 2014-05-28 | Research Foundation Itsuu Laboratory | Antimicrobial compounds |
CN101868228B (zh) | 2007-11-21 | 2016-12-07 | 大日本住友制药株式会社 | 口腔内崩解片 |
TR200806298A2 (tr) | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Farmasötik formülasyon |
ATE525064T1 (de) | 2009-07-01 | 2011-10-15 | Tiefenbacher Alfred E Gmbh & Co Kg | Pharmazeutische zusammensetzung mit desloratadin |
ES2709487T3 (es) | 2010-05-10 | 2019-04-16 | Lesvi Laboratorios Sl | Formulaciones farmacéuticas estables que contienen un antihistamínico |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003707A1 (en) * | 1984-02-15 | 1985-08-29 | Schering Corporation | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
US4657716A (en) | 1984-03-19 | 1987-04-14 | Lim Kunststoff Technologie Gesellschaft | Method of making elastomeric shoe soles |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
US5595997A (en) | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
PE71699A1 (es) * | 1997-02-07 | 1999-08-03 | Sepracor Inc | Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra |
-
1999
- 1999-07-08 DE DE69940932T patent/DE69940932D1/de not_active Expired - Lifetime
- 1999-07-08 WO PCT/US1999/012368 patent/WO2000002560A1/en active IP Right Grant
- 1999-07-08 ID IDW20010070A patent/ID28645A/id unknown
- 1999-07-08 PT PT99933484T patent/PT1073438E/pt unknown
- 1999-07-08 ES ES03023240T patent/ES2326214T3/es not_active Expired - Lifetime
- 1999-07-08 IL IL13940799A patent/IL139407A0/xx not_active IP Right Cessation
- 1999-07-08 KR KR10-2000-7012430A patent/KR100420641B1/ko not_active IP Right Cessation
- 1999-07-08 AU AU49531/99A patent/AU741201B2/en not_active Expired
- 1999-07-08 EP EP03023240A patent/EP1380297B1/en not_active Expired - Lifetime
- 1999-07-08 PT PT03023240T patent/PT1380297E/pt unknown
- 1999-07-08 BR BR9910449-0A patent/BR9910449A/pt not_active Application Discontinuation
- 1999-07-08 ES ES99933484T patent/ES2214871T3/es not_active Expired - Lifetime
- 1999-07-08 NZ NZ512916A patent/NZ512916A/xx not_active IP Right Cessation
- 1999-07-08 CN CNB998068497A patent/CN1145485C/zh not_active Expired - Lifetime
- 1999-07-08 HU HU0101900A patent/HU228448B1/hu unknown
- 1999-07-08 CZ CZ20004056A patent/CZ300843B6/cs unknown
- 1999-07-08 PL PL344045A patent/PL199390B1/pl unknown
- 1999-07-08 EP EP09002742A patent/EP2055303A3/en not_active Withdrawn
- 1999-07-08 EP EP99933484A patent/EP1073438B1/en not_active Revoked
- 1999-07-08 DK DK03023240T patent/DK1380297T3/da active
- 1999-07-08 NZ NZ507885A patent/NZ507885A/en not_active IP Right Cessation
- 1999-07-08 AT AT03023240T patent/ATE432075T1/de active
- 1999-07-08 AR ARP990103342A patent/AR016044A1/es not_active Application Discontinuation
- 1999-07-08 AT AT99933484T patent/ATE262904T1/de active
- 1999-07-08 CA CA002325014A patent/CA2325014C/en not_active Expired - Lifetime
- 1999-07-08 DE DE69916042T patent/DE69916042T2/de not_active Expired - Lifetime
- 1999-07-08 CA CA002377178A patent/CA2377178A1/en not_active Abandoned
- 1999-07-08 SK SK1711-2000A patent/SK288240B6/sk not_active IP Right Cessation
- 1999-07-08 JP JP2000558820A patent/JP3224379B1/ja not_active Expired - Lifetime
- 1999-07-08 DK DK99933484T patent/DK1073438T3/da active
- 1999-07-09 TW TW088111680A patent/TW575424B/zh not_active IP Right Cessation
- 1999-07-09 MY MYPI99002889A patent/MY116038A/en unknown
- 1999-07-09 PE PE1999000697A patent/PE20000761A1/es not_active IP Right Cessation
-
2000
- 2000-07-17 AR ARP000103668A patent/AR021158A2/es unknown
- 2000-07-17 AR ARP000103669A patent/AR021159A1/es not_active Application Discontinuation
- 2000-07-17 AR ARP000103667A patent/AR021157A2/es unknown
- 2000-10-31 NO NO20005485A patent/NO331454B1/no not_active IP Right Cessation
- 2000-11-01 ZA ZA200006224A patent/ZA200006224B/xx unknown
-
2001
- 2001-02-10 HK HK01100972A patent/HK1030361A1/xx not_active IP Right Cessation
- 2001-07-04 JP JP2001204138A patent/JP4160739B2/ja not_active Expired - Lifetime
-
2005
- 2005-07-08 JP JP2005200665A patent/JP4621082B2/ja not_active Expired - Lifetime
-
2009
- 2009-08-10 CY CY20091100846T patent/CY1109279T1/el unknown
-
2010
- 2010-08-26 JP JP2010190099A patent/JP2010265329A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109279T1 (el) | Στοματικες συνθεσεις με βαση την 8-chloro-6,11-dihydro-11-(4-piperidylidene) -5h-benzo[5,6]-cyclo-hepta[1,2-b]pyridine | |
HUP0203870A2 (hu) | Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény | |
BG103430A (en) | FACTOR Xa INHIBITING HETEROCYCLIC DERIVATIVES | |
DK0496796T3 (da) | Fremgangsmåde og præparater til inhibering af sygdomme i forbindelse med oxidativ beskadigelse | |
DE69931159D1 (de) | Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat | |
UA70298A (uk) | Похідні с-4"-заміщених макролідів, спосіб їх одержання, проміжні сполуки, фармацевтична композиція та спосіб лікування бактеріальної інфекції або протозойної інфекції | |
DK0853083T3 (da) | Pyridylfuran- og piridylthiophenforbindelser og farmaceutisk anvendelse deraf | |
GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
GB9914486D0 (en) | Medicaments | |
DE60041973D1 (de) | Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivität | |
NO950774L (no) | Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol | |
GEP20043161B (en) | Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators | |
PT828728E (pt) | Di-hidrobenzofuranos de fenilo | |
HUP0103063A2 (hu) | Új 2H-piridazin-származékok, alkalmazásuk, ilyen hatóanyagot tartalmazó gyógyászati készítmények, és eljárás a hatóanyag előállítására | |
BR9915480A (pt) | Azalìdeos de 13 membros e a sua utilização como agentes antibióticos | |
BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
TR200000223T2 (tr) | XA faktörünü engelleyen heterosiklik türevler | |
ATE230404T1 (de) | Cyclohexyldihydrobenzofurane | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
BR0002577A (pt) | Suspensões orais de trovafloxacina | |
DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
BR0105775A (pt) | Compostos de n-benzenossulfonil-l-prolina como antagonistas da bradiquinina | |
EE04058B1 (et) | Benso[c]kinolisiini derivaadid, nende valmistamine ja kasutamine 5a-reduktaasi inhibiitoritena | |
HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
NO20006547L (no) | Salter av paroxetine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL.8: A61K 31/4545, A61K 31/4523, A61K 9/20, A61K 47/38, A61P 37/08 Ipc: A61K 31/4545 (2007.10), A61K 31/4523 (2007.10), A6 |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA COMO ESTABELECIDO PELOS ARTIGOS 8O E 13 DA LPI ( LEI 9729/96 ) |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B15Z | Prolongation of time limit refused |
Free format text: INTERESSADO: ACHE LABORATORIOS FARMACEUTICOS S/A DESPACHO: NEGADA A DEVOLUCAO DE PRAZO SOLICITADADE ACORDO COM O ARTIGO 2O, PARAGRAFO UNICO, DA RESOLUCAO NO116/04. |
|
B25D | Requested change of name of applicant approved |
Owner name: MERCK SHARP AND DOHME CORP. (US) |
|
B25G | Requested change of headquarter approved |
Owner name: MERCK SHARP AND DOHME CORP. (US) |